PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för alendronic acid. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

15 hits

Bibliografisk träff 2015-07-01

Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially.

Whitmarsh T, Treece GM, Gee AH, Poole KE.

J Bone Miner Res · research support, non-u.s. gov't; journal article · DOI 10.1002/jbmr.2454

Bibliografisk träff 2015-01-30

Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts.

Soydan SS, Araz K, Senel FV, Yurtcu E, Helvacioglu F, Dagdeviren A, Tekindal MA, Sahin F.

Hum Exp Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1177/0960327115569808

Bibliografisk träff 2015-01-21

Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.

Pasqualetti S, Congiu T, Banfi G, Mariotti M.

Int J Exp Pathol · research support, non-u.s. gov't; journal article · DOI 10.1111/iep.12106

Bibliografisk träff 2015-01-16

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.

Sakai A, Ito M, Tomomitsu T, Tsurukami H, Ikeda S, Fukuda F, Mizunuma H, Inoue T, Saito H, Nakamura T, e-ADVANCED Study Group.

Osteoporos Int · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1007/s00198-014-2991-z

Bibliografisk träff 2015-01-13

Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.

Bae J, Park JW.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2015.01.020

Bibliografisk träff 2015-01-12

Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate.

Hardy BT, de Brito Galvao JF, Green TA, Braudaway SR, DiBartola SP, Lord L, Chew DJ.

J Vet Intern Med · clinical trial; research-article; journal article · DOI 10.1111/jvim.12507

Bibliografisk träff 2015-01-11

Ex vivo alendronate localization at the mesoporous titania implant/bone interface.

Karlsson J, Harmankaya N, Allard S, Palmquist A, Halvarsson M, Tengvall P, Andersson M.

J Mater Sci Mater Med · journal article · DOI 10.1007/s10856-014-5337-7

Bibliografisk träff 2014-11-17

The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.

Ishtiaq S, Edwards S, Sankaralingam A, Evans BA, Elford C, Frost ML, Fogelman I, Hampson G.

Cytokine · randomized controlled trial; journal article · DOI 10.1016/j.cyto.2014.10.025

Bibliografisk träff 2014-10-23

Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs.

Burr DB, Liu Z, Allen MR.

Bone · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bone.2014.10.010

Bibliografisk träff 2014-10-15

Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties.

Hassler N, Gamsjaeger S, Hofstetter B, Brozek W, Klaushofer K, Paschalis EP.

Osteoporos Int · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1007/s00198-014-2929-5

Bibliografisk träff 2014-10-14

Effects of alendronate on osteoclast formation and activity in vitro.

Martins CA, Leyhausen G, Volk J, Geurtsen W.

J Endod · research support, non-u.s. gov't; journal article · DOI 10.1016/j.joen.2014.07.010

Bibliografisk träff 2014-03-28

Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases.

Ballas EG, Mavrogenis AF, Karamanis E, Kokkalis ZT, Mitsiokapa E, Koulalis D, Mastrokalos D, Papagelopoulos PJ.

Eur J Orthop Surg Traumatol · journal article; case reports · DOI 10.1007/s00590-014-1443-y

Bibliografisk träff 2009-10-01

In vitro determination of the release of alendronic acid from alendronate tablets of different brands during deglutition.

Lamprecht G.

J Pharm Sci · journal article · DOI 10.1002/jps.21639

Bibliografisk träff 2006-03-18

Inhibitory effects of alendronate on cholinergic responses in rat lower esophageal sphincter.

Takeuchi T, Nakamura A, Nakajima H, Azuma YT, Hata F.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2006.03.027

Bibliografisk träff 2003-04-01

Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.

Reichenberg A, Hintz M, Kletschek Y, Kuhl T, Haug C, Engel R, Moll J, Ostrovsky DN, Jomaa H, Eberl M.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(03)00138-0